MELE Stock Analysis: Melexis | BR
Semiconductors | BR, Belgium | Market Cap: 2.821m EUR | 12M Return: 7.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.36M
EPS Trend: -92.3%
Qual. Beats: 0
Rev. Trend: -74.3%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Melexis NV (MELE) is a Belgian semiconductor company that designs, develops, and markets advanced integrated semiconductor devices, primarily serving the automotive industry across Europe, the Middle East, Africa, Asia Pacific, and the Americas. Founded in 1988 and headquartered in Ieper, Belgium, the company offers a broad portfolio that includes a wide range of sensor ICs (current, position, speed, pressure, temperature, tire monitoring, and time-of-flight), embedded motor and lighting driver ICs, and transceiver ICs supporting protocols such as LIN, CAN, and RFID. As a mid-cap firm in the Information Technology sector, Melexis generates most of its revenue from automotive-grade analog and mixed-signal semiconductors, a segment that has seen sustained growth driven by increasing electronic content per vehicle, particularly in electrified and advanced driver-assistance (ADAS) applications.
- Automotive sensor demand recovers as global car production normalizes
- Electric vehicle adoption lifts semiconductor content per vehicle
- Inventory destocking in automotive chips pressures gross margins
| Net Income: 111.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA 5.68 > 1.0 |
| NWC/Revenue: 52.20% < 20% (prev 45.01%; Δ 7.18% < -1%) |
| CFO/TA 0.24 > 3% & CFO 201.7m > Net Income 111.0m |
| Net Debt (221.5m) to EBITDA (205.2m): 1.08 < 3 |
| Current Ratio: 5.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.5m) vs 12m ago -1.99% < -2% |
| Gross Margin: 39.00% > 18% (prev 41.64%; Δ -2.64% > 0.5%) |
| Asset Turnover: 96.07% > 50% (prev 98.27%; Δ -2.21% > 0%) |
| Interest Coverage Ratio: 15.34 > 6 (EBIT TTM 151.6m / Interest Expense TTM 9.88m) |
| A: 0.52 (Total Current Assets 547.3m - Total Current Liabilities 107.1m) / Total Assets 851.2m |
| B: 0.66 (Retained Earnings 562.7m / Total Assets 851.2m) |
| C: 0.17 (EBIT TTM 151.6m / Avg Total Assets 878.0m) |
| D: 1.42 (Book Value of Equity 499.1m / Total Liabilities 352.0m) |
| Altman-Z'' = 8.20 = AAA |
| DSRI: 1.05 (Receivables 116.1m/116.3m, Revenue 843.5m/889.2m) |
| GMI: 1.07 (GM 41.64% / 39.00%) |
| AQI: 0.59 (AQ_t 0.12 / AQ_t-1 0.20) |
| SGI: 0.95 (Revenue 843.5m / 889.2m) |
| TATA: -0.11 (NI 111.0m - CFO 201.7m) / TA 851.2m) |
| Beneish M = -3.21 (Cap -4..+1) = AA |
As of July 29, 2026, the stock is trading at EUR 68.65 with a total of 43,563 shares traded. Over the past week, the price has changed by -0.58%, over one month by -10.32%, over three months by -0.39% and over the past year by +7.16%.
Current recommended Stop Loss: 64.20 (which is 6.5% or 1.4 ATR below the current price).
Melexis has no consensus analysts rating.
P/E Trailing = 26.1496
P/E Forward = 22.9885
P/S = 3.345
P/B = 5.8458
P/EG = 2.2264
Revenue TTM = 843.5m EUR
EBIT TTM = 151.6m EUR
EBITDA TTM = 205.2m EUR
Long Term Debt = 233.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 12.2m EUR (from shortTermDebt, last quarter)
Debt = 258.6m EUR (from shortLongTermDebtTotal, last quarter) + Leases 7.21m
Net Debt = 221.5m EUR (calculated: Debt 258.6m - CCE 37.1m)
Enterprise Value = 3.04b EUR (2.82b + Debt 258.6m - CCE 37.1m)
Interest Coverage Ratio = 15.34 (Ebit TTM 151.6m / Interest Expense TTM 9.88m)
EV/FCF = 18.14x (Enterprise Value 3.04b / FCF TTM 167.7m)
FCF Yield = 5.51% (FCF TTM 167.7m / Enterprise Value 3.04b)
FCF Margin = 19.89% (FCF TTM 167.7m / Revenue TTM 843.5m)
Net Margin = 13.16% (Net Income TTM 111.0m / Revenue TTM 843.5m)
Gross Margin = 39.00% ((Revenue TTM 843.5m - Cost of Revenue TTM 514.5m) / Revenue TTM)
Gross Margin QoQ = 39.89% (prev 38.37%)
Tobins Q-Ratio = 3.57 (Enterprise Value 3.04b / Total Assets 851.2m)
Interest Expense / Debt = 3.82% (Interest Expense 9.88m / Debt 258.6m)
Taxrate = 18.53% (25.2m / 136.2m)
NOPAT = 123.5m (EBIT 151.6m * (1 - 18.53%))
Current Ratio = 5.11 (Total Current Assets 547.3m / Total Current Liabilities 107.1m)
Debt / Equity = 0.52 (Debt 258.6m / totalStockholderEquity, last quarter 499.1m)
Debt / EBITDA = 1.08 (Net Debt 221.5m / EBITDA 205.2m)
Debt / FCF = 1.32 (Net Debt 221.5m / FCF TTM 167.7m)
Total Stockholder Equity = 506.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.64% (Net Income 111.0m / Total Assets 851.2m)
RoE = 21.91% (Net Income TTM 111.0m / Total Stockholder Equity 506.7m)
RoCE = 20.48% (EBIT 151.6m / Capital Employed (Equity 506.7m + L.T.Debt 233.5m))
RoIC = 17.17% (NOPAT 123.5m / Invested Capital 719.2m)
WACC = 8.73% (E(2.82b)/V(3.08b) * Re(9.24%) + D(258.6m)/V(3.08b) * Rd(3.82%) * (1-Tc(0.19)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -71.00 | Cagr: -1.01%
[DCF] Terminal Value 76.76% ; FCFF base≈151.4m ; Y1≈173.6m ; Y5≈255.4m
[DCF] Fair Price = 85.95 (EV 3.61b - Net Debt 221.5m = Equity 3.38b / Shares 39.4m; r=8.73% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -92.33 | EPS CAGR: -25.03% | SUE: -0.41 | # QB: 0
Revenue Correlation: -74.30 | Revenue CAGR: -5.40% | SUE: 0.48 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.73 | Chg30d=-1.68% | Revisions=-40% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.87 | Chg30d=+2.37% | Revisions=-40% | Analysts=3
EPS current Year (2026-12-31): EPS=3.01 | Chg30d=+0.63% | Revisions=+0% | GrowthEPS=+8.1% | GrowthRev=+2.1%
EPS next Year (2027-12-31): EPS=3.91 | Chg30d=+2.80% | Revisions=+25% | GrowthEPS=+30.1% | GrowthRev=+10.3%
[Analyst] Revisions Ratio: -38% (up=1, down=4)